In the ever-evolving landscape of clinical research, adaptation is not just a necessity — it is a driving force behind innovation. As we reflect on our third year attending DPHARM: Disruptive...
Read More
The ophthalmologist shortage affects clinical trials with ocular endpoints. With only 1 ophthalmologist for every 17,235 patients, sponsors and CROs face endpoint access challenges. This workforce...
Read More
In 2022, DPHARM: Disruptive Innovations to Modernize Clinical Research Conference brought industry leaders together to explore three factors essential to innovation in clinical trials:
Read More
In late April, several members from our Life Sciences team attended and exhibited at the Association for Research in Vision and Ophthalmology(ARVO) 2023 Annual Meeting in New Orleans, LA.
Read More
Non-ophthalmic trials in oncology, endocrinology, CNS disorders, and rare disease frequently rely on ocular safety endpoints, but most research sites don't routinely provide eye care and lack the...
Read More
This October, several members of our Life Sciences team had the opportunity to attend the 2022 SCRS Global Site Solutions Summit as an Alliance Sponsor. The Summit is committed to being known as “the...
Read More
Biopharma and life science leaders are calling this patient-first approach "optionality": some participants prefer traveling to a trial site, while others can't due to cost or time constraints, and a...
Read More
People with language barriers often struggle to get the care they need, and they may even avoid seeking care altogether. At 20/20 Onsite, we want every patient who comes aboard a Mobile Vision Clinic...
Read More